CLINICAL SUPPLY MANAGEMENT ARTICLES
How Early Signals Prevent Risk In Clinical Trial Supply Chains
Small shifts in forecasts, RTSM behavior, and inventory can reveal future supply risks. Learn how early signals help clinical teams prevent disruptions before they escalate.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
Explore how the optimization of Interactive Response Technologies (IRT) settings relieved the burden of managing global supply needs for a CRO customer and clinical sponsor.
-
Learn how protocol-driven IRT systems support supply management and randomization to help trial teams cut risk and costs.
-
Drive excellence in clinical trials by utilizing forecasting to better plan clinical supply budgets and project timelines, and identify potential supply-related issues before they negatively impact a study.
-
Signant’s SmartSignals® RTSM solution helped an innovative biopharmaceutical company secure an FDA Orphan Drug designation for its cardiomyopathy drug.
-
Explore how Interactive Response Technologies (IRTs) built around microservices models can provide faster initial builds, more rapid change management, and improved built-in test automation.
-
Looking ahead, the evolution of RTSM in clinical trials points towards cloud-based solutions, heightened emphasis on patient safety, and greater collaboration among stakeholders. Learn how you can prepare.
-
Patient enrollment can vary widely due to a number of variables, introducing risk into the supply chain. Here's why its critical to be aware of these risks and how best to mitigate them within trials.